TORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults ...
The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.
What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...
The U.S. Centers for Disease Control and Prevention decided to hold off recommending the use of the vaccine, Arexvy, in ...
IGA score of cleared (0) or minimal disease (1) was achieved by a significantly greater proportion of those in the guselkumab vs placebo group, 74.2% vs 12.4%, respectively. Arexvy is currently ...
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...
The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...
Consumer Reports on MSN11d
4 Vaccines You Might Need Right Now
That means that if you haven’t gotten vaccines already, it’s time to put them on your to-do list. But which ones should you ...
GSK's vaccine sales, including RSV and Shingrix, decline amid changing US recommendations, impacting Q3 performance and ...
GSK's shares are falling 4% in premarket trading Wednesday after the British pharma giant posted lower-than-estimated quarterly sales and lowered its projection for vaccine sales ...
Arexvy still had about a two-thirds share of the retail market, where most of the doses are given. Chief executive Dame Emma Walmsley said the strong performance in cancer treatments and HIV medicine ...